Gary Lee Feiss
Keine laufenden Positionen mehr
Profil
Gary Lee Feiss held positions as Director of Clinical Trials at OraSure Technologies, Vice President of Regulatory Affairs at Covalent Group, and VP of Clinical Development & Regulatory Affairs at Saladax Biomedical.
Ehemalige bekannte Positionen von Gary Lee Feiss
| Unternehmen | Position | Ende |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
| Covalent Group, Inc. | General Counsel | - |
Saladax Biomedical, Inc.
 Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | General Counsel | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Saladax Biomedical, Inc.
Saladax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA. | Commercial Services |
| Covalent Group, Inc. | Commercial Services |
